PDB49 Resource Use in Patients with Type 2 Diabetes (T2D) Who Initiated Exenatide BID (EXBID) or Starter Insulin (INS) Therapy- 6-Month Data from Choice
Abstract
Authors
M. Theodorakis M.D. Reaney D. Bruhn S. Matthaei C. Mathieu J. Kiljanski B. Guerci H. Sapin C.G. Östenson C. Salaun-Martin T. Krarup